Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Heparin-Induced Thrombocytopenia and Thrombosis
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the phenomenon of Heparin-Induced Thrombocytopenia (HIT) and its associated thrombotic complications, particularly in the context of vaccination. The papers cover various aspects including pathogenesis, diagnosis, management, immune response, and the role of anticoagulation therapy in HIT. Additionally, they explore the clinical features and outcomes related to HIT and thrombosis.
130
Works
IDs:OpenAlex
How has Heparin-Induced Thrombocytopenia and Thrombosis's publication output changed over time?
ScholarIQpublication output · 1985–2024
Output grew0% over the shown period — from 1 works in 1985 to 1 in 2024.
1
1
1
2
3
4
1
1
1
198519932000201620182021202220232024
What are the most-cited papers on Heparin-Induced Thrombocytopenia and Thrombosis?
ScholarIQmost cited works
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
Adam Cuker, Gowthami M. Arepally, Beng H. Chong, Douglas B. Cines, Andreas Greinacher, Yves Gruel, Lori Ann Linkins, Stephen B. Rodner, Sixten Selleng, Theodore E. Warkentin, Ashleigh Wex, Reem A. Mustafa, Rebecca L. Morgan, Nancy Santesso
Blood Advances. 2018736 CitationsOPEN ACCESS
Thrombocytopenia and prognosis in intensive care
Steven Vanderschueren, Annick De Weerdt, Manu L. N. G. Malbrain, D Vankersschaever, Eric Frans, Alexander Wilmer, Herman Bobbaers
Critical Care Medicine. 2000597 Citations
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
Colin R Simpson, Ting Shi, Eleftheria Vasileiou, Srinivasa Vittal Katikireddi, Stephen J. Kerr, Emily Moore, Colin McCowan, Utkarsh Agrawal, Syed Ahmar Shah, Lewis Ritchie, Josie Murray, Jiafeng Pan, Declan Bradley, Sarah J. Stock, Rachael Wood, Antony Chuter, Jillian Beggs, Helen R. Stagg, Mark Joy, Ruby S. M. Tsang, Simon de Lusignan, Richard Hobbs, Ronan A Lyons, Fatemeh Torabi, Stuart Bedston, Michael P. O’Leary, Ashley Akbari, Jim McMenamin, Chris Robertson, Aziz Sheikh
Nature Medicine. 2021263 CitationsOPEN ACCESS
Heparin-Induced Thrombocytopenia
Benjamin Salter, Menachem M. Weiner, Muoi Trinh, J Heller, Adam S. Evans, David Adams, Gregory W. Fischer
Journal of the American College of Cardiology. 2016213 CitationsOPEN ACCESS
Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
Andreas Greinacher, Kathleen Selleng, Julia Mayerle, Raghavendra Palankar, Jan Wesche, Sven Reiche, Andrea Aebischer, Theodore E. Warkentin, Maximilian Muenchhoff, Johannes C. Hellmuth, Oliver T. Keppler, Daniel Duerschmied, Achim Lother, Siegbert Rieg, Meinrad Gawaz, Karin Anne Lydia Mueller, Christian Scheer, Matthias Napp, Klaus Hahnenkamp, Guglielmo Lucchese, Antje Vogelgesang, Agnes Flöel, Piero Lovreglio, Angela Stufano, Rolf Marschalek, Thomas Thiele, for the Immune-Response in COVID-19 Vaccination Study Group
Blood. 2021127 CitationsOPEN ACCESS
Where is Heparin-Induced Thrombocytopenia and Thrombosis research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Heparin-Induced Thrombocytopenia and Thrombosis is open access?
ScholarIQopen access share
67%OPEN ACCESS
Gold
33%
Green
7%
Hybrid
7%
Bronze
20%
Closed
33%
Related on ScholarIQ
Prevention of VTE in Nonsurgical Patients
Paper
Bivalirudin for Patients with Acute Coronary Syndromes
Paper
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Paper
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Paper
Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
Paper
EULAR recommendations for the management of antiphospholipid syndrome in adults
Paper